Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy
2019 · Nature Medicine · 367 citations
https://doi.org/10.1038/s41591-019-0461-z
M
Magali Noval Rivas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
6.2K
Citations
36
h-index
55
i10-index
Magali Noval Rivas is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Kawasaki Disease and Coronary Complications & Inflammasome and immune disorders & Coronary Artery Anomalies. The author has an h-index of 36, co-authored 88 publications.
ORCID: 0000-0001-5570-8928Papers by this author
worksRegulatory T Cell Reprogramming toward a Th2-Cell-like Lineage Impairs Oral Tolerance and Promotes Food Allergy
2015 · Immunity · 357 citations
https://doi.org/10.1016/j.immuni.2015.02.004
Loss of testosterone impairs anti-tumor neutrophil function
2020 · Nature Communications · 60 citations
https://doi.org/10.1038/s41467-020-15397-4
Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes
2024 · EMBO Molecular Medicine · 16 citations
https://doi.org/10.1038/s44321-024-00093-3
Gut Microbiota Alterations in Patients With Kawasaki Disease
2025 · Arteriosclerosis Thrombosis and Vascular Biology · 12 citations
https://doi.org/10.1161/atvbaha.124.321201
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat